Service
-
For Authors
How to submit, copyright, proposals, discount.
-
For Librarians
Ejournals, ebooks, collections, pricing, usage statistics.
-
For Book Reviewers
How to request a book,
terms and conditions.
Our (e)Books and (e)Journals
IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.
Browse by Subject
IOS Press publishes books and journals (online and in print) in a broad range of scientific, technical and medical (STM) subject areas. Click on a subject above to see our titles.
Service
-
For Authors
How to submit, copyright, proposals, discount.
-
For Librarians
Ejournals, ebooks, collections, pricing, usage statistics.
-
For Book Reviewers
How to request a book,
terms and conditions.
News
Keep me informedWhen We Are Born Can Influence How Mentally Fit We Will Be in Old Age
July 29, 2021 - Prague, Czechia – According to a study published in Journal of Alzheimer's Disease, people born in winter seem to carry a life-long disadvantage in cognitive ageing. Specifically, their cognitive skills are lower when compared to people born in other seasons, even when taking into account other influencing characteristics, such as their education, depression or cardiovascular diseases.
July 29, 2021Latest Journal Citation Reports Shows Significant Impact Factor Increases for IOS Press Journals
July 28, 2021 - Amsterdam, NL – IOS Press, an independent international publisher of scientific, technical, and medical (STM) journals and books, is pleased to announce significant increases in the Journal Impact Factors (JIFs) of two of its flagship journals in neurogenerative diseases. The Journal of Parkinson’s Disease JIF has increased by 7.5% to 5.568, positioning it in the first quartile of Neuroscience journals with a ranking of 62 among 270 journals in that category. The Journal of Alzheimer’s Disease, the most highly cited journal devoted exclusively to this disease, rose by an impressive 14.4% to 4.472.
July 28, 2021Keystone Bio Advances a More Complete Explanation of Porphyromonas Gingivalis Toxic Virulence Factors
July 27, 2021 - St. Louis, MO, USA – Keystone Bio, a biotechnology company, is a frontrunner in developing precision biologics to eliminate Porphyromonas gingivalis (Pg) and is releasing groundbreaking data that shows bacterial toxic proteins from Pg in the mouth are released into the blood and cross the blood-brain barrier (BBB) as the major driver of sporadic Alzheimer’s disease (AD) and chronic inflammation.
July 27, 2021Digital Pens Provide New Insight into Cognitive Testing Results
July 12, 2021 - Boston, MA, USA – During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to evaluate how well specific domains of their cognition are functioning. Consider, though, two participants who achieve the same score on one of these paper-and-pencil neuropsychological tests. One took 60 seconds to complete the task and was writing the entire time; the other spent three minutes, and alternated between writing answers and staring off into space. If researchers analyzed only the overall score of these two participants, would they be missing something important?
July 12, 2021